Welcome to the forefront of conversational AI as we explore the fascinating world of AI chatbots in our dedicated blog series. Discover the latest advancements, applications, and strategies that propel the evolution of chatbot technology. From enhancing customer interactions to streamlining business processes, these articles delve into the innovative ways artificial intelligence is shaping the landscape of automated conversational agents. Whether you’re a business owner, developer, or simply intrigued by the future of interactive technology, join us on this journey to unravel the transformative power and endless possibilities of AI chatbots.
A recent international survey concluded that medical researchers have a positive attitude toward using AI chatbots, but ethical and accuracy concerns require further interventions to create systematic, unified rules.
This international cross-sectional survey was published in January 2026 in Cureus.
Applying AI Guidelines in Research Journey – Differing Stance
Artificial Intelligence (AI) driven large language models (LLMs) like Google Bard, Gemini, Bing AI, and ChatGPT are designed to generate human-like responses. They assist the scientific community with literature reviews, writing, data analysis, and citations. While guidelines exist for AI chatbot use in research, acceptance varies among publishers: Springer Nature and Science reject ChatGPT as a coauthor, while many Elsevier journals permit its disclosed use. Studies have shown that ChatGPT produces coherent writing with low plagiarism but faces challenges with accuracy, fabricated references, and ethical concerns.
Study Overview
An observational, cross-sectional survey was conducted to assess the use and perceptions of AI chatbots among 434 medical researchers. The survey was administered online and targeted participants across multiple countries. Medical researchers who had either published at least one study or were currently involved in a medical research project and resided in Saudi Arabia, Nigeria, Tunisia, or the United Kingdom (England), regardless of nationality, were included. Those who had never conducted or contributed to a research project, those outside the countries mentioned, and those not in the medical field were excluded. The primary outcomes included self-reported use of AI chatbots in research (binary: yes/no) and perceptions of AI chatbots’ impact on research. Additional outcome measures included participants’ ethical stances (e.g., whether they believe guidelines are needed) and future intentions regarding AI chatbot use. Key explanatory variables included participants’ demographic characteristics, such as age group, gender, country, and professional role.
Key Findings
Possible Medical Researcher & Stakeholder Implications
AI has gained attention in scientific publishing for its ability to generate human-like text. Its strength lies in its ability to process large volumes of text quickly, potentially reducing researchers’ workloads. ChatGPT and similar tools trained on vast text corpora support language tasks at scale. These models can automate previously manual tasks, such as reviewing papers and extracting key elements. AI chatbots can benefit authors when used responsibly. While they cannot replace subject-matter expertise, they may assist in drafting descriptions, organising manuscripts, supporting literature tasks, and refining research questions. However, the risks include a lack of context, inaccuracy, and bias in the outputs.
Reference: Alturaiki H M, Al Khamees M M, Alradhi H A, et al. The Use and Perceptions of AI Chatbots in Medical Research: An International Cross-Sectional Survey. Cureus 18(1): e100908. Published January 06, 2026. DOI 10.7759/cureus.100908
Dr Bhumika Maikhuri is an orthodontist with 2 years of clinical experience. She is also working as a medical writer and anchor at Medical Dialogues. She has completed her BDS from Dr D.Y. Patil Medical College and Hospital and MDS from Kalinga Institute of Dental Sciences. She has a few publications and patents to her credit. Her diverse background in clinical dentistry and academic research uniquely positions her to contribute meaningfully to our team.
Editorial
Lifestyle-Linked CV Risk: Where Does Aspirin Fit?
Redefining Diabetes Management With Dapagliflozin and Sitagliptin FDC: An Early, Effective and…
Considering Triple Agents in Glucose Control – Application & Safety Considerations in 2026
Case Management of Chemotherapy Induced Anemia (CIA) with Darbepoetin Alfa in a Patient with …
ROBUST Study Released: One of the Largest Beta-Blocker KAP Study Captures Place of Beta Blockers in…
Journal Club Today
8-Hour Eating Window Reduced Crohn’s Disease Activity by 40 Percent in Trial
Health News Today
Health Bulletin 13/February/2026
